Group music therapy for chronic depression

StudY oN group music therapy for CHRONic depression: an exploratory pilot to assess feasibilitY of a randomised controlled trial with wait-list control

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN18164037

Enrollment

Registered

2016-09-26

Start date

2016-10-01

Completion date

Unknown

Last updated

2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Specialty: Mental Health, Primary sub-specialty: Depression

Interventions

Participants will be randomised individually with unbalanced allocation to the intervention and control groups (2:1). Intervention group: Participants undertake group music therapy. The treatment wil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Adults aged 18 or above 2. Confirmed diagnosis of depression (ICD10 F31-39, F20.4, F43) 3. Receiving treatment for depression 12 months or longer 4. Capacity to give informed consent

Exclusion criteria

Exclusion criteria: 1. Diagnosis of organic mental disorder (ICD10 F00-09) 2. Bipolar affective disorder- current manic episode 3. No capacity to give informed consent 4. Risk of suicide necessitating hospitalisation

Design outcomes

Primary

Measure	Time frame
1. Acceptability of methodology to professionals and patients is determined through review of recruitment rates, compliance rates and interviews at 6 months post-intervention 2. Feasibility of recruitment processes is determined through assessing recruitment rate at study end 3. Eligibility, participating and retention rates are measured through screening, recruitment and attendance logs at study end 4. Researcher time and costs per participant is assessed using researcher time diaries at study end 5. Feasibility of the intervention is measured by reviewing attendance rates of participants, use of components by therapists throughout the intervention period of 14 weeks, and adherence to the intervention manual by therapists in the same period 6. Acceptability of the intervention is measured by the estimation of likely intervention effect after 14 weeks, 1, 3 and 6 month follow-ups across the measures of symptoms of: depression, psychological distress, social functioning, self-esteem, self-efficacy, satisfaction with treatment, work and social adjustment, service use and quality of life	—

Measure

Time frame

1. Acceptability of methodology to professionals and patients is determined through review of recruitment rates, compliance rates and interviews at 6 months post-intervention 2. Feasibility of recruitment processes is determined through assessing recruitment rate at study end 3. Eligibility, participating and retention rates are measured through screening, recruitment and attendance logs at study end 4. Researcher time and costs per participant is assessed using researcher time diaries at study end 5. Feasibility of the intervention is measured by reviewing attendance rates of participants, use of components by therapists throughout the intervention period of 14 weeks, and adherence to the intervention manual by therapists in the same period 6. Acceptability of the intervention is measured by the estimation of likely intervention effect after 14 weeks, 1, 3 and 6 month follow-ups across the measures of symptoms of: depression, psychological distress, social functioning, self-esteem, self-efficacy, satisfaction with treatment, work and social adjustment, service use and quality of life

—

Secondary

Measure	Time frame
1. Observer rated depression is measured at baseline, 1, 3 and 6 months post-intervention 2. Self-reported depression is measured at baseline, 1, 3 and 6 months post-intervention 3. Psychological distress is measured at baseline, 1, 3 and 6 months post-intervention 4. Social functioning is measured at baseline, 1, 3 and 6 months post-intervention 5. Self-esteem is measured at baseline, 1, 3 and 6 months post-intervention 6. Self-efficacy is measured at baseline, 1, 3 and 6 months post-intervention 7. Mood is measured using The Dispositional Mood Scale at pre and post session 8. Relationships are measured using Relationship Satisfaction Scale (RSS)(weekly, session 2, pre & post) 9. Satisfaction with treatment is measured at baseline, 1, 3 and 6 months post-intervention 10. Work and social adjustment is measured at baseline, 1, 3 and 6 months post-intervention 11. Hospitalisation is measured at baseline, 1, 3 and 6 months post-intervention 12. Quality of Life is measured at baseline, 1, 3 and 6 months post-intervention	—

Measure

Time frame

1. Observer rated depression is measured at baseline, 1, 3 and 6 months post-intervention 2. Self-reported depression is measured at baseline, 1, 3 and 6 months post-intervention 3. Psychological distress is measured at baseline, 1, 3 and 6 months post-intervention 4. Social functioning is measured at baseline, 1, 3 and 6 months post-intervention 5. Self-esteem is measured at baseline, 1, 3 and 6 months post-intervention 6. Self-efficacy is measured at baseline, 1, 3 and 6 months post-intervention 7. Mood is measured using The Dispositional Mood Scale at pre and post session 8. Relationships are measured using Relationship Satisfaction Scale (RSS)(weekly, session 2, pre & post) 9. Satisfaction with treatment is measured at baseline, 1, 3 and 6 months post-intervention 10. Work and social adjustment is measured at baseline, 1, 3 and 6 months post-intervention 11. Hospitalisation is measured at baseline, 1, 3 and 6 months post-intervention 12. Quality of Life is measured at baseline, 1, 3 and 6 months post-intervention

—

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 10, 2026